Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg
Prior Bariatric Surgery May Protect Against Severe COVID-19 Outcomes
Among COVID-19-positive adults, outcomes better for those with prior bariatric surgery versus those eligible for bariatric surgery
CDC: More Than 100,000 Americans Died From Drug Overdoses in One Year
Figure is almost 30 percent higher than the previous year, when 78,000 overdose deaths were reported
White House to Spend Billions to Boost COVID-19 Vaccine Supply
The goal of the plan is to produce at least 1 billion doses a year beginning in the second half of 2022
FDA Could Approve Pfizer Booster Shots for All Adults This Week
More than 30 million Americans have already gotten booster shots
Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries
Countries included in licensing deal mostly in Africa and Asia and account for more than half of the world’s population
Two Doses of 10 μg BNT162b2 Safe, Efficacious in 5- to 11-Year-Olds
BNT162b2 vaccine had favorable safety profile in 5- to 11-year-olds similar to that seen in other age groups
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
Request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness
COVID-19 Vaccine Protection Wanes, But They Are Our Best Defense
New studies show that first-generation COVID-19 vaccines effectively reduce severe disease but quickly lose their protective value.
In the context of the continuous emergence of SARS-CoV-2 coronavirus variants, and a potential fourth wave accelerating in Europe, these studies suggest enhancing COVID-19 vaccination coverage is still the most critical and urgent priority.